Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Papulosquamous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06347237
What this trial is testing

PsA Digital Phenotyping and Inflammation Drivers Study

Who this might be right for
Psoriatic ArthritisFlare Up, SymptomPsoriatic Arthritis Aggravated
Jolanda Luime 600
Not applicableUnknownNCT05954572
What this trial is testing

Association Between Biologic Therapy and Demodex Density in Psoriasis Patients: A Comparative Study

Who this might be right for
Demodicidosis
Hasan Aksoy 34
Post-approval studies (Phase 4)Study completedNCT00462072
What this trial is testing

Centocor Microarray Study of Patients

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisPsoriasis+1 more
University of Rochester 31
Not applicableLooking for participantsNCT07615257
What this trial is testing

Managing Psychological Distress Through Mindfulness-based CBT to Evaluate Its Effectiveness on Self-compassion Among Psoriasis Patients:The Mediating Role of Mental Health Locus of Control

Who this might be right for
Psoriasis
Islamia University of Bahawalpur 128
Not applicableNot Yet RecruitingNCT07793773
What this trial is testing

Disease Impact and Its Correlation With Disease Activity in Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Assiut University 80
Post-approval studies (Phase 4)Looking for participantsNCT07160231
What this trial is testing

REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases

Who this might be right for
Rheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)Axial Spondyloarthritis (AxSpA)
Sint Maartenskliniek 200
Not applicableStudy completedNCT02849795
What this trial is testing

Evaluation of Adipokines and Fat Tissue in Psoriasis and Psoriatic Arthritis

Who this might be right for
PsoriasisArthritic Psoriasis
Centre Hospitalier Universitaire de Besancon 199
Not applicableNot Yet RecruitingNCT07381595
What this trial is testing

Role of Subgingival Instrumentation in Oral Lichen Planus

Who this might be right for
Oral Lichen Planus
Postgraduate Institute of Dental Sciences Rohtak 30
Not applicableNot Yet RecruitingNCT07022756
What this trial is testing

Personalized Outreach for Equitable Treatment in Rheumatology

Who this might be right for
Rheumatic DiseasesInflammatory ArthritisRheumatoid Arthritis (RA)+2 more
University of British Columbia 20
Large-scale testing (Phase 3)Study completedNCT00115076
What this trial is testing

Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Rockefeller University 31
Large-scale testing (Phase 3)UnknownNCT01352780
What this trial is testing

Psoriasis and Climate Therapy- Effect of Motivational Follow- up Calls on Clinical and Health Economic Parameters

Who this might be right for
Psoriasis
Oslo University Hospital 169
Post-approval studies (Phase 4)Study completedNCT03567980
What this trial is testing

A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis

Who this might be right for
Seborrheic Dermatitis
University of Alabama at Birmingham 30
Post-approval studies (Phase 4)Study completedNCT00096980
What this trial is testing

Evaluate Raptiva in Combination With Topical Psoriasis Therapies

Who this might be right for
Psoriasis
Genentech, Inc. 300
Post-approval studies (Phase 4)Ended earlyNCT04028713
What this trial is testing

Dose Tapering Study of Adalimumab in Psoriasis

Who this might be right for
Psoriasis Vulgaris
University Hospital, Ghent 19
Early research (Phase 1)Study completedNCT05225623
What this trial is testing

Small Changes Behavioural Weight Loss Treatment Approach for Psoriatic Arthritis Patients With Comorbid Obesity

Who this might be right for
Psoriatic ArthritisObesity
University of Calgary 38
Large-scale testing (Phase 3)Study completedNCT06588296
What this trial is testing

Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight

Who this might be right for
Psoriatic ArthritisObesity
Eli Lilly and Company 279
Not applicableStudy completedNCT00162825
What this trial is testing

Role of CD7 in Skin Inflammation and Psoriasis

Who this might be right for
PsoriasisInflammation
National Taiwan University Hospital 30
Large-scale testing (Phase 3)Study completedNCT00235820
What this trial is testing

Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 271
Large-scale testing (Phase 3)Study completedNCT00293917
What this trial is testing

Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

Who this might be right for
Psoriasis
Astellas Pharma Inc 658
Not applicableNot Yet RecruitingNCT07450625
What this trial is testing

Efficacy of Collagendep in Reducing Vulvar Dryness in Patients With Lichen Sclerosus Treated With Fat Grafting

Who this might be right for
Vulvar Lichen SclerosusVulvar Atrophy
San Gallicano Dermatological Institute IRCCS 40
Next Page